Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Vivasrheumatological

Phys Vivas · rheumatological

Complement Deficiencies AND Recurrent Infections — Viva Defence

DCE viva defence for Complement Deficiencies AND Recurrent Infections.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
DCE viva defence for Complement Deficiencies AND Recurrent Infections.

Complement Deficiencies AND Recurrent Infections Viva

Long Case Viva Defence

Opening statement

"This patient presents with a problem best framed as Complement Deficiencies AND Recurrent Infections. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]

Examiner questions

Q1: "What makes this urgent?" [1]

"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]

Q2: "What is your first investigation package?" [2]

"I order tests that change management now, not a scattergun panel." [1] [2]

Q3: "Walk me through treatment." [1]

"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]

Q4: "What is the classic trap?" [2]

"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]

Short case

Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]

References

  1. [1]Mottaghipisheh H, Jahromi AM, Mirzaei F, Meri S, et al. Homozygous C1qA Deficiency Presenting as Early-Onset Systemic Lupus Erythematosus: A Case Report With a Literature Review Case Reports Immunol, 2026.PMID 42147803
  2. [2]Consolini R, Maestrini G, Abu-Rumeileh S, Costagliola G The Intertwining Between Arthritis and Inborn Errors of Immunity J Clin Med, 2026.PMID 42123030
  3. [3]Boccon-Gibod I, Fain O, Gobert D, Debord S, et al. French protocol for the diagnosis and management of hereditary angioedema Rev Med Interne, 2025.PMID 41168057
  4. [4]Schejbel L, Fadnes D, Permin H, Lappegård KT, et al. Primary complement C5 deficiencies - molecular characterization and clinical review of two families Immunobiology, 2013.PMID 23743184
  5. [5]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  6. [6]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
  7. [7]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
  8. [8]Donadoni M, La Cava L, Bizzi E, Popescu Janu V, et al. Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile Medicina (Kaunas), 2025.PMID 41303734